The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis
Lymphangioleiomyomatosis (LAM) is a destructive cystic lung disease. Mammalian target of rapamycin (mTOR) inhibitors are the primary treatment for LAM but it is unknown whether these immunosuppressing medications increase the risk for or the severity of respiratory infections in LAM patients. We sea...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2017-01-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/26/143/160004.full |